SCDS - ETF AI Analysis
Top Page
JPMorgan Fundamental Data Science Small Core ETF (SCDS)
SCDS, the JPMorgan Fundamental Data Science Small Core ETF, has a solid overall rating supported by strong holdings like AZZ, WSFS Financial, and Monarch Casino & Resort, which show healthy financial performance, reasonable valuations, and generally positive technical trends. The fund’s score is held back somewhat by weaker names such as Twist Bioscience and Concentra Group Holdings, where profitability, cash flow, and technical challenges introduce more risk. A key risk factor is the ETF’s exposure to smaller companies, which can face higher volatility and operational uncertainty even when growth prospects look promising.
SCDS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 9.57M
- Region
- North America
- Expense Ratio
- 0.40%
- Beta
- 1.01
- Issuer
- JPMorgan
- Inception Date
- Aug 07, 2024
- Dividend Yield
- 1.11%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
SCDS Summary
SCDS is the JPMorgan Fundamental Data Science Small Core ETF, focused on smaller U.S. companies that JPMorgan selects using data science instead of tracking a traditional index. It spreads investments across many sectors, including financials, health care, and technology, and holds names like The Chefs’ Warehouse and Twist Bioscience. Someone might consider this ETF for growth potential and diversification, since small companies can expand faster than large ones. However, small-cap stocks can be more volatile, so the value of this ETF can go up and down more sharply with the market.
How much will it cost me?
This ETF has an expense ratio of 0.40%, which means you’ll pay about $4 per year for every $1,000 you invest. That’s a bit higher than the average low-cost index ETF because it’s actively managed using JPMorgan’s data science approach to pick small-cap stocks.
What would affect this ETF?
Because SCDS focuses on U.S. small-cap stocks across sectors like financials, health care, technology, and consumer cyclical, it could benefit from a strong U.S. economy, rising corporate profits, and innovation in areas such as biotech and software that support holdings like Twist Bioscience and Moog. On the other hand, higher interest rates, economic slowdowns that hurt smaller companies and consumer spending, or tighter financial and health care regulations could weigh on its diverse mix of banks, energy firms, real estate, and leisure-related names such as Monarch Casino & Resort and Life Time Group Holdings.
SCDS Top 10 Holdings
SCDS leans into U.S. small caps with a mix of niche growth stories and steady operators. Twist Bioscience has been a big swing factor, surging over the year but recently losing some steam, while Concentra’s strong run has quietly powered returns despite operational hiccups. Consumer and leisure names like The Chefs’ Warehouse and Life Time Group have been rising overall, adding a healthy dose of cyclical exposure. On the flip side, Moog and Monarch Casino look more mixed lately, occasionally dragging on performance. Sector-wise, the fund tilts toward financials, tech, and health care, all firmly rooted in the U.S. market.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 TWST | Twist Bioscience | 1.14% | $109.10K | $10.06B | 390.15% | 43Neutral |
 RHP | Ryman | 1.10% | $105.37K | $9.09B | 55.02% | 66Neutral |
 CHEF | The Chefs' Warehouse | 0.88% | $83.99K | $4.53B | 73.80% | 72Outperform |
 WSFS | Wsfs Financial | 0.93% | $89.08K | $4.01B | 48.53% | 78Outperform |
 LTH | Life Time Group Holdings | 0.96% | $92.20K | $10.13B | 83.41% | 71Outperform |
 AZZ | AZZ | 0.86% | $82.67K | $4.02B | 35.47% | 79Outperform |
 MOG.A | Moog | 0.89% | $84.90K | $11.10B | 68.24% | 73Outperform |
 CON | Concentra Group Holdings Parent, Inc. | 0.83% | $79.08K | $5.15B | 101.10% | 66Neutral |
 MCRI | Monarch Casino & Resort | 0.61% | $58.67K | $1.98B | 23.23% | 78Outperform |
SCDS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCDS, the sentiment is Neutral. The current price of 72.33 is above the 20-day moving average (MA) of 71.87, below the 50-day MA of 72.86, and above the 200-day MA of 70.03, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 50.56 is Neutral, neither overbought nor oversold. The STOCH value of 83.94 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SCDS.
SCDS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| SCDS | $72.33 | $78.00(7.84% Upside) | $9.57M | 0.40% | 64Neutral |
 RUSC | $36.75 | $50.00(36.04% Upside) | $85.25M | 0.64% | 64Neutral |
 AIMS | $26.93 | $34.54(28.30% Upside) | $84.74M | 0.75% | 65Neutral |
 SYZ | $29.36 | $36.87(25.58% Upside) | $63.23M | 0.61% | 66Neutral |
 ESSC | $28.85 | $38.16(32.29% Upside) | $34.73M | 0.49% | 66Neutral |
 FTKI | $19.52 | $23.45(20.12% Upside) | $25.61M | 0.86% | 63Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 72.33 | 13.57 | 23.10% | |
| RUSC | US Small Cap Equity Active ETF | 36.75 | 6.32 | 20.75% | |
| AIMS | Acuitas Small Cap Active ETF | 26.93 | 1.75 | 6.93% | |
| SYZ | Lazard US Systematic Small Cap Equity ETF | 29.36 | 5.08 | 20.93% | |
| ESSC | Eventide Small Cap ETF | 28.85 | 3.77 | 15.02% | |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 19.52 | 3.18 | 19.45% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.